STOK logo

Stoke Therapeutics, Inc. (STOK) Accounts Payable

Annual Accounts Payable:

$2.50M+$803.00K(+47.37%)
December 31, 2024

Summary

  • As of today, STOK annual accounts payable is $2.50 million, with the most recent change of +$803.00 thousand (+47.37%) on December 31, 2024.
  • During the last 3 years, STOK annual accounts payable has risen by +$113.00 thousand (+4.74%).
  • STOK annual accounts payable is now at all-time high.

Performance

STOK Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKbalance sheet metrics

Quarterly Accounts Payable:

$5.87M+$1.56M(+36.12%)
September 30, 2025

Summary

  • As of today, STOK quarterly accounts payable is $5.87 million, with the most recent change of +$1.56 million (+36.12%) on September 30, 2025.
  • Over the past year, STOK quarterly accounts payable has increased by +$3.39 million (+136.26%).
  • STOK quarterly accounts payable is now at all-time high.

Performance

STOK Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

STOK Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+47.4%+136.3%
3Y3 Years+4.7%+207.2%
5Y5 Years+232.6%+436.2%

STOK Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+226.1%at high+666.5%
5Y5-Yearat high+232.6%at high+796.3%
All-TimeAll-Timeat high+1671.6%at high+796.3%

STOK Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$5.87M(+36.1%)
Jun 2025
-
$4.31M(+97.3%)
Mar 2025
-
$2.19M(-12.5%)
Dec 2024
$2.50M(+47.4%)
$2.50M(+0.5%)
Sep 2024
-
$2.48M(-37.0%)
Jun 2024
-
$3.94M(+87.7%)
Mar 2024
-
$2.10M(+24.0%)
Dec 2023
$1.70M(+121.3%)
$1.70M(-44.9%)
Sep 2023
-
$3.08M(+97.7%)
Jun 2023
-
$1.56M(-63.8%)
Mar 2023
-
$4.30M(+461.2%)
Dec 2022
$766.00K
$766.00K(-59.9%)
Sep 2022
-
$1.91M(-46.9%)
Jun 2022
-
$3.60M(+8.2%)
DateAnnualQuarterly
Mar 2022
-
$3.33M(+39.5%)
Dec 2021
$2.38M(+59.5%)
$2.38M(+264.1%)
Sep 2021
-
$655.00K(-32.0%)
Jun 2021
-
$963.00K(-35.6%)
Mar 2021
-
$1.50M(+0.1%)
Dec 2020
$1.50M(+99.1%)
$1.50M(+36.5%)
Sep 2020
-
$1.09M(+21.1%)
Jun 2020
-
$904.00K(-49.2%)
Mar 2020
-
$1.78M(+136.9%)
Dec 2019
$751.00K(-29.9%)
$751.00K(-58.0%)
Sep 2019
-
$1.79M(+44.5%)
Jun 2019
-
$1.24M(+9.9%)
Mar 2019
-
$1.13M(+5.1%)
Dec 2018
$1.07M(+659.6%)
$1.07M
Dec 2017
$141.00K
-

FAQ

  • What is Stoke Therapeutics, Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Stoke Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of STOK is $2.50M

What is the all-time high annual accounts payable for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual accounts payable is $2.50M

What is Stoke Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, STOK annual accounts payable has changed by +$803.00K (+47.37%)

What is Stoke Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of STOK is $5.87M

What is the all-time high quarterly accounts payable for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly accounts payable is $5.87M

What is Stoke Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, STOK quarterly accounts payable has changed by +$3.39M (+136.26%)
On this page